Literature DB >> 3166140

Organization of the human alpha 2-plasmin inhibitor gene.

S Hirosawa1, Y Nakamura, O Miura, Y Sumi, N Aoki.   

Abstract

We have isolated overlapping phage genomic clones covering an area of 26 kilobases that encodes the human alpha 2-plasmin inhibitor. The alpha 2-plasmin inhibitor gene contains 10 exons and 9 introns distributed over approximately 16 kilobases of DNA. To our knowledge, the number of introns is the highest yet reported for a member of the serine protease inhibitor (serpin) superfamily. All introns are located in the 5'-half of the corresponding mRNA. The 5'-untranslated region and the leader sequence are interrupted by 3 introns totaling approximately equal to 6 kilobases. A "TATA box" sequence is located 17 nucleotides upstream from the proposed transcription initiation site. Multiple "GC box" sequences, G + C-rich sequences, and "CCAAT box"-like sequence, the hepatitis B virus enhancer element-like sequence and the human immunodeficiency virus enhancer-like sequence appear in the 5'-flanking region. The NH2-terminal region, which implements factor XIII-catalyzed cross-linking of alpha 2-plasmin inhibitor to fibrin, is encoded by the 4th exon. The reactive site and plasminogen-binding site, both located in the COOH-terminal region, are encoded by the 10th exon. When similar amino acids of alpha 2-plasmin inhibitor and other members of the serpin gene superfamily are aligned, the position of the 7th intron of the alpha 2-plasmin inhibitor gene aligns precisely with that of the second intron of the genes for rat angiotensinogen and human alpha 1-antitrypsin genes and is misaligned by only one nucleotide with that of the third intron of antithrombin III, suggesting that the alpha 2-plasmin inhibitor gene originates from the common ancestor of these serine protease inhibitors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3166140      PMCID: PMC282073          DOI: 10.1073/pnas.85.18.6836

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

Review 1.  Inhibitors of the fibrinolytic enzyme system.

Authors:  N Aoki; P C Harpel
Journal:  Semin Thromb Hemost       Date:  1984-01       Impact factor: 4.180

2.  Transcriptional control signals of a eukaryotic protein-coding gene.

Authors:  S L McKnight; R Kingsbury
Journal:  Science       Date:  1982-07-23       Impact factor: 47.728

3.  Genetic abnormalities of the fibrinolytic system.

Authors:  N Aoki
Journal:  Semin Thromb Hemost       Date:  1984-01       Impact factor: 4.180

4.  Related genes can have unrelated introns.

Authors:  A Cornish-Bowden
Journal:  Nature       Date:  1982-06-24       Impact factor: 49.962

Review 5.  Organization and expression of eucaryotic split genes coding for proteins.

Authors:  R Breathnach; P Chambon
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

6.  Post-translational processing of full-length presecretory proteins with canine pancreatic signal peptidase.

Authors:  R C Jackson; G Blobel
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

7.  Cross-linking of alpha 2-plasmin inhibitor to fibrin catalyzed by activated fibrin-stabilizing factor.

Authors:  T Tamaki; N Aoki
Journal:  J Biol Chem       Date:  1982-12-25       Impact factor: 5.157

8.  Sequence homology and structural comparison between the chromosomal human alpha 1-antitrypsin and chicken ovalbumin genes.

Authors:  M Leicht; G L Long; T Chandra; K Kurachi; V J Kidd; M Mace; E W Davie; S L Woo
Journal:  Nature       Date:  1982-06-24       Impact factor: 49.962

9.  Fibrin-associated plasminogen activation in alpha 2-plasmin inhibitor deficiency.

Authors:  N Aoki; Y Sakata; A Ichinose
Journal:  Blood       Date:  1983-11       Impact factor: 22.113

10.  Intron structure of the human antithrombin III gene differs from that of other members of the serine protease inhibitor superfamily.

Authors:  E V Prochownik; S C Bock; S H Orkin
Journal:  J Biol Chem       Date:  1985-08-15       Impact factor: 5.157

View more
  8 in total

1.  Regulation of the human protein C inhibitor gene expression in HepG2 cells: role of Sp1 and AP2.

Authors:  T Hayashi; M Usui; J Nishioka; Z X Zhang; K Suzuki
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

Review 2.  The plasmin-antiplasmin system: structural and functional aspects.

Authors:  Johann Schaller; Simon S Gerber
Journal:  Cell Mol Life Sci       Date:  2010-12-07       Impact factor: 9.261

3.  The effect of a single nucleotide polymorphism on human alpha 2-antiplasmin activity.

Authors:  Victoria J Christiansen; Kenneth W Jackson; Kyung N Lee; Patrick A McKee
Journal:  Blood       Date:  2007-02-22       Impact factor: 22.113

4.  Molecular basis for congenital deficiency of alpha 2-plasmin inhibitor. A frameshift mutation leading to elongation of the deduced amino acid sequence.

Authors:  O Miura; S Hirosawa; A Kato; N Aoki
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

5.  Low nucleotide diversity in man.

Authors:  W H Li; L A Sadler
Journal:  Genetics       Date:  1991-10       Impact factor: 4.562

6.  Criteria for the Specific Measurement of Plasmin Inhibitor Activity Using an Enzymatic Procedure.

Authors:  Piet Meijer; Michel Hanss; Ulla Christensen; Bjorn Wiman; Kees Kluft
Journal:  EJIFCC       Date:  2001-07-22

7.  Plasmin inhibitor deficiency: A case report.

Authors:  Ouissal Aissaoui; Rachid Cherkab; Lahoucine Barrou
Journal:  Clin Case Rep       Date:  2020-01-07

8.  Generation and characterization of monoclonal antibodies against the N-terminus of alpha-2-antiplasmin.

Authors:  Shiraazkhan Abdul; Miet Peeters; Els Brouwers; Joyce J M C Malfliet; Frank W G Leebeek; Paul J Declerck; Dingeman C Rijken; Shirley Uitte de Willige
Journal:  PLoS One       Date:  2018-05-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.